Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Super-Resolution Imaging Technology Locates Specific DNA Sequences

By LabMedica International staff writers
Posted on 21 Oct 2013
With the use of advanced optical tools and sophisticated mathematics, researchers have found a way to target the location of specific sequences along single strands of DNA, a technique that could someday help diagnose genetic diseases.

Proof-of-concept research in the Rice University (Houston, TX, USA) lab of chemist Dr. More...
Christy Landes identified DNA sequences as short as 50 nucleotides at room temperature, an achievement she noted is unfeasible with conventional microscopes that cannot see objects that tiny, or electron microscopes that require targets to be cryogenically frozen or in a vacuum.

The technique called super-localization microscopy has been known for a while, according to Dr. Landes, but its application in biosensing is in its early stages. Scientists have seen individual double-stranded DNA molecules under optical microscopes for a long time, but the ability to visualize single-stranded DNA is a new achievement, and breaking the diffraction limit of light adds value, she noted.

The study was published online September 27, 2013, in the American Chemical Society journal Applied Materials and Interfaces. The Rice researchers call their super-resolution technique motion blur point accumulation for imaging in nanoscale topography (mbPAINT). Using it, they resolved structures as small as 30 nm by making, fundamentally, a movie of fluorescent DNA probes flowing over a known target sequence along an immobilized single strand of DNA.

The probes are labeled with a fluorescent dye that lights up only when attached to the target DNA. In the experimental setup, most would flow by unseen, but some would bind to the target for a few milliseconds, just long enough to be captured by the camera before the moving liquid pulled them away. Processing images of these brief occurrences among the background blur allows the researchers to image objects smaller than the natural diffraction limits of light-based imaging, which do not allow for the resolution of targets smaller than the wavelength of light used to illuminate them.

Even the Dr. Landes lab’s system is subject to these physical boundaries. Individual images of fluorescing probes on targets are only a pixelated blur. However, it is a blur with a bright spot, and comprehensive analysis of multiple images allows the investigators to locate that spot along the strand.

Dr. Landes reported one objective for mbPAINT is to map minute fragments of DNA. “Eventually, we’d like to get down to a couple of nucleotides,” she said. “Some diseases are characterized by one amino acid mutation, which is three nucleotides, and there are many diseases associated with very small genetic mutations that we’d like to be able to identify. We’re thinking this method will be ideally suited for diseases associated with small, localized mutations that are not possible to detect in any other inexpensive way.”

Dr. Landes envisions mpPAINT as not only more cost-effective but also able to capture information electron microscopes cannot. “One of the reasons people invented electron microscopy is to image objects smaller than light’s diffraction limit, because biomolecules such as proteins and DNAs are smaller than that,” she said. “But electron microscopy requires cryogenic temperatures or a vacuum. You can’t easily watch things react in solution. The advent of this technology allows us to see the biological processes of nano-sized objects as they happen in water, with buffers and salts, at room temperature, at body temperature or even in a cell. It’s very exciting.”

Related Links:

Rice University



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.